CXCL2 and acute respiratory distress syndrome: Additionally, significant inhibition of TNF-α, IL-6, and CXCL-2 was evident in the dose-ranging ALI treatment study with 15 mg/kg omadacycline administered 6 hours post-LPS challenge (Fig. S4).